Bill > A06222

This bill establishes the "340B prescription drug anti-discrimination act," which protects healthcare providers participating in the 340B drug discount program from unfair treatment by pharmaceutical manufacturers and pharmacy benefit managers. The 340B program, authorized by federal law, allows certain healthcare organizations like hospitals, clinics, and community health centers to purchase prescription drugs at significantly reduced prices. The bill prohibits these manufacturers and managers from discriminating against covered entities and New York state pharmacies by: (1) denying or limiting drug dispensing, (2) refusing to provide access to drugs based on 340B program participation, and (3) imposing different requirements, fees, or conditions on 340B participants compared to non-participants. If any entity violates these provisions, the commissioner of health can impose civil monetary penalties and will refer the matter to the education department and attorney general's office. Any contract terms that contradict the bill's provisions will be considered void and unenforceable. The bill defines key terms like "covered entity," "contract pharmacy," and "dispensing" to ensure clear implementation, and it is designed to protect healthcare providers' ability to access discounted medications through the 340B program.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/A6222